Safety and immunogenicity of a novel hexavalent group B streptococcus conjugate vaccine in healthy, non-pregnant adults: a phase 1/2, randomised, placebo-controlled, observer-blinded, dose-escalation trial

Autor: Absalon, Judith *, Segall, Nathan, Block, Stan L, Center, Kimberly J, Scully, Ingrid L, Giardina, Peter C, Peterson, James, Watson, Wendy J, Gruber, William C, Jansen, Kathrin U, Peng, Yahong, Munson, Samantha, Pavliakova, Danka, Scott, Daniel A, Anderson, Annaliesa S
Zdroj: In The Lancet Infectious Diseases February 2021 21(2):263-274
Databáze: ScienceDirect